Good morning :)
Place Order
Add to Watchlist

Bacil Pharma Ltd

BACPHAR Share Price

40.565.00% (+1.93)

BACPHAR Share Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹23 cr, stock is ranked 4,017
Moderate RiskStock is 2.95x as volatile as Nifty

BACPHAR Stock Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹23 cr, stock is ranked 4,017
Moderate RiskStock is 2.95x as volatile as Nifty

BACPHAR Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
66.3619.58—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.006.390.53%

BACPHAR Analyst Ratings & Forecast

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

BACPHAR Company Profile

Bacil Pharma is engaged in the business of manufacturing of pharmaceuticals, medicinal chemicals and botanical products.

BACPHAR Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
44.71
1Y Return
14.01%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
29.86
1Y Return
5.19%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
65.86
1Y Return
26.18%
Buy Reco %
68.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.93
1Y Return
2.08%
Buy Reco %
45.16
Mankind Pharma Ltd
MANKIND
PE Ratio
52.09
1Y Return
13.24%
Buy Reco %
80.00
Compare with Peers

BACPHAR Forecasts

Price

Revenue

Earnings

BACPHAR Share Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BACPHAR Company Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BACPHAR Stock EPS (Earnings Per Share) Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BACPHAR

Income

Balance Sheet

Cash Flow

BACPHAR Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.63%, vs industry avg of 9.04%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.060.170.270.090.140.070.060.110.130.59
Raw Materialssubtract0.000.000.000.000.000.000.000.000.000.23
Power & Fuel Costsubtract0.000.000.000.010.000.000.000.000.00
Employee Costsubtract0.040.080.130.080.090.050.060.090.10
Selling & Administrative Expensessubtract0.090.080.130.160.080.080.090.080.08
Operating & Other expensessubtract0.000.013.730.180.270.173.760.040.01
Depreciation/Amortizationsubtract0.000.000.010.010.010.000.000.000.00—
Interest & Other Itemssubtract0.000.000.030.000.010.000.000.000.00—
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.00—
EPS-0.110.00-6.38-0.59-0.54-0.39-6.54-0.17-0.100.61
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.00—0.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

BACPHAR Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

BACPHAR Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bacil Pharma Ltd-398.1619.58—
Sun Pharmaceutical Industries Ltd44.716.380.76%
Cipla Ltd29.864.590.85%
Torrent Pharmaceuticals Ltd65.8615.910.87%

BACPHAR Stock Price Comparison

Compare BACPHAR with any stock or ETF
Compare BACPHAR with any stock or ETF
BACPHAR
Loading...

BACPHAR Shareholdings

BACPHAR Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 32.07%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

BACPHAR Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 4.30%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

BACPHAR Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding10.60%0.00%0.00%0.00%89.40%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

BACPHAR Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.00%0.00%0.00%

BACPHAR Insider Trades & Bulk Stock Deals

Loading...

smallcases containing BACPHAR stock

Looks like this stock is not in any smallcase yet.

BACPHAR Events

BACPHAR Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BACPHAR has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

BACPHAR Dividends

Hmm, looks like data is unavailable here. Please come back after some time

BACPHAR Stock News & Opinions

Earnings
Bacil Pharma reports standalone net loss of Rs 0.06 crore in the December 2024 quarter

Net Loss of Bacil Pharma reported to Rs 0.06 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Bacil Pharma to discuss results

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 21 January 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Bacil Pharma to convene EGM

Bacil Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 14 November 2024 .Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Bacil Pharma reports standalone net profit of Rs 0.48 crore in the September 2024 quarter

Net profit of Bacil Pharma reported to Rs 0.48 crore in the quarter ended September 2024 as against net loss of Rs 0.01 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Bacil Pharma to convene board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Bacil Pharma schedules board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 15 October 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Bacil Pharma announces board meeting date

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 27 September 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Bacil Pharma to conduct AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Bacil Pharma schedules AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Bacil Pharma reports standalone net loss of Rs 0.03 crore in the June 2024 quarter

Net loss of Bacil Pharma reported to Rs 0.03 crore in the quarter ended June 2024 as against net profit of Rs 0.02 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Bacil Pharma Ltd (BACPHAR) today?

    The share price of BACPHAR as on 21st March 2025 is ₹40.56. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Bacil Pharma Ltd (BACPHAR) share?

    The past returns of Bacil Pharma Ltd (BACPHAR) share are
    • Past 1 week: 0.60%
    • Past 1 month: -11.34%
    • Past 3 months: -33.84%
    • Past 6 months: 55.16%
    • Past 1 year: 199.78%
    • Past 3 years: 372.73%
    • Past 5 years: 2217.71%

  3. What are the peers or stocks similar to Bacil Pharma Ltd (BACPHAR)?

    The peers or stocks similar to Bacil Pharma Ltd (BACPHAR) include:

  4. What is the market cap of Bacil Pharma Ltd (BACPHAR) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bacil Pharma Ltd (BACPHAR) is ₹23.89 Cr as of 21st March 2025.

  5. What is the 52 week high and low of Bacil Pharma Ltd (BACPHAR) share?

    The 52-week high of Bacil Pharma Ltd (BACPHAR) is ₹62.56 and the 52-week low is ₹13.53.

  6. What is the PE and PB ratio of Bacil Pharma Ltd (BACPHAR) stock?

    The P/E (price-to-earnings) ratio of Bacil Pharma Ltd (BACPHAR) is -398.16. The P/B (price-to-book) ratio is 19.58.

  7. Which sector does Bacil Pharma Ltd (BACPHAR) belong to?

    Bacil Pharma Ltd (BACPHAR) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Bacil Pharma Ltd (BACPHAR) shares?

    You can directly buy Bacil Pharma Ltd (BACPHAR) shares on Tickertape. Simply sign up, connect your demat account and place your order.